Trial · NCT07888244
Medical Payment Case Management for Financial Toxicity in Patients With Primary Bone Tumors: A Randomized Controlled Trial
NCT07888244, Not applicable, Recruiting, Shanghai 6th People's Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Medical Payment Case Management for Financial Toxicity in Patients With Primary Bone Tumors: A Randomized Controlled Trial. Trials, record NCT07888244. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07888244
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Medical Payment Case Management for Financial Toxicity in Patients With Primary Bone Tumors: A Randomized Controlled Trial
- NCT number
- NCT07888244
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 124 participants, estimated
- Lead sponsor
- Shanghai 6th People's Hospital
- Conditions
- Bone Tumor, Bone Cancer
- Interventions
- Medical payment case management service
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Financial Toxicity Score | Baseline and 6 months | Financial toxicity is assessed with the 11-item Comprehensive Score for Financial Toxicity (COST-FACIT), each item scored 0-4 for a total of 0-44, with lower scores indicating greater financial toxicity. The outcome is the change in total score from baseline to 6 months after enrollment. |
| Secondary | Incidence of Catastrophic Health Expenditure | 6 months and 9 months | Catastrophic health expenditure is defined as cumulative out-of-pocket medical costs of 10% or more of annual household income. Out-of-pocket costs are obtained from hospital billing and settlement records and from patient-reported out-of-hospital spending; annual household income is self-reported at baseline. Incidence is the number of patients meeting the threshold divided by the group total. |
| Secondary | Incidence of Cost-Related Treatment Non-Adherence | 6 months and 9 months | Proportion of patients who, because of treatment costs, downgraded their prosthesis or reconstruction, abandoned treatment, interrupted rehabilitation, or reduced chemotherapy. Assessed with a structured questionnaire administered at follow-up visits. |
| Secondary | Incidence of Cost-Coping Strategies | 6 months and 9 months | Proportion of patients reporting at least one of seven cost-coping behaviors: considering abandoning treatment, delaying treatment by more than 7 days, not taking medication as prescribed, missing follow-up visits, reducing leisure spending, reducing basic medical service spending, and borrowing money or taking loans because of illness. Assessed with a seven-item yes/no questionnaire. |
| Secondary | Out-of-Pocket Costs as a Percentage of Annual Household Income | 6 months | Cumulative out-of-pocket medical costs divided by annual household income, expressed as a percentage. Costs are collected from hospital billing and settlement records and from patient-reported out-of-hospital expenses; annual household income is self-reported at baseline. |
| Secondary | Change in Caregiver Burden Score | Baseline, 6 months, 9 months, and 12 months | Caregiver burden is assessed with the 12-item Zarit Burden Interview (ZBI-12). Each item is scored 0-4, giving a total score of 0-48, with higher scores indicating greater burden. Reported as the change in total score from baseline. |
| Secondary | Patient Satisfaction with Overall Care Score | 6 months and 12 months | Patient-rated satisfaction with the overall care received during the study, on an 11-point numeric rating scale from 0 (least satisfied) to 10 (most satisfied). |
| Other | Follow-up completion rate | 9 months | Proportion of participants who complete the post-surgical follow-up visits scheduled by their treating physician. |
| Other | Resolution rate of catastrophic health expenditure | 9 and 12 months | Proportion of participants who met the catastrophic health expenditure threshold at 9 months after enrollment and no longer met it at 12 months after enrollment. |
| Other | Decomposition of the reduction in out-of-pocket spending by payment channel | 6 and 9 months | For each payment channel - basic medical insurance secondary reimbursement, critical illness insurance, supplemental medical insurance, charity assistance, commercial insurance claims, pharmaceutical company assistance, social assistance, compliant fundraising, and the pediatric catastrophic illness assistance program - the amount contributed to the reduction in out-of-pocket spending and its share of the total reduction. |
1 to 10 of 15Source ClinicalTrials.gov
See all 15 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers8
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07888244
GET https://conductscience.org/api/trials/v1/NCT07888244/registered